{"id":"W4396869098","doi":"10.1080/09546634.2024.2324833","title":"Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials","year":2024,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"Eli Lilly and Company","keywords":"Medicine; Atopic dermatitis; Randomized controlled trial; Placebo; Dermatology; Clinical trial; Clinical efficacy; Internal medicine; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001079442,0.0003442815,0.00336637,0.0002794232,0.00004132691,0.00004034254,0.0001518652,0.0002501947,0.0001142275],"category_scores_gemma":[0.002999127,0.0001759627,0.0009514957,0.0002334654,0.0002141857,0.0001328766,0.0000367869,0.0003874605,0.00002916169],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001903068,"about_ca_system_score_gemma":0.0003616113,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000142428,"about_ca_topic_score_gemma":0.00001415753,"domain_scores_codex":[0.993859,0.001511431,0.003466631,0.0003626613,0.000501871,0.0002983843],"domain_scores_gemma":[0.9933856,0.004871964,0.0008016749,0.0002973869,0.0002167415,0.0004266155],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6727442,0.02547287,0.2341185,0.0002028647,0.004109898,0.01039052,0.000425624,0.0001582105,0.000004134308,0.0001200497,0.008168519,0.04408466],"study_design_scores_gemma":[0.6362518,0.002121658,0.3534811,0.002317958,0.002094906,0.0007535993,0.00005134847,0.0005852006,0.0003839102,0.000963426,0.0007691967,0.0002259125],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.989645,0.004051215,0.000914754,0.003007993,0.0003308079,0.001574739,0.0001852784,0.00003252761,0.0002576975],"genre_scores_gemma":[0.997575,0.000535108,0.001046488,0.0005578851,0.0001095487,0.00003285064,0.0001051486,0.00001845235,0.00001948888],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1193626,"threshold_uncertainty_score":0.717555,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1029242243129192,"score_gpt":0.3948028931438463,"score_spread":0.291878668830927,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}